Evaluating third generation cervical Cancer intracavitary interstitial brachytherapy applicator efficacy and safety

This study evaluated the therapeutic effect of a third-generation intracavitary interstitial brachytherapy (IC-ISBT) technique combined with a source applicator template for locally advanced cervical cancer. This retrospective study examined 113 patients with stage IB3-IVB disease admitted to Sun Yat-sen University Cancer Center between January 2023 and January 2024. The high-risk clinical target area was defined based on residual tumor after external irradiation, and a third-generation IC-ISBT source donor template was developed. We compared the dosimetry and efficacy of the donor template (template interpolation group) and traditional manual implantation method (manual interpolation group) for treating cervical cancer. Regarding dosimetry coverage, the template group differed significantly from the freehand group, showing better target suitability (index) and dose coverage (V100%) (both P < 0.01). Simultaneously, the template protected the rectum and sigmoid colon, potentially reducing the high-dose areas (D0.1 cm³). However, the primary cervical remission rates did not differ significantly between groups. The study findings indicate that the design of the third-generation IC-ISBT applicator template was scientific and reasonable, especially for patients with large tumor volumes and late-stage disease. It is easy to operate and highly reproducible, proving beneficial for dose distribution and protecting surrounding key structures.